deltatrials
Unknown OBSERVATIONAL NCT05831553

TIP in Patients Affected by Metastatic TNBC (TIP)

Evaluation of a Tissue Immune Profile (TIP) in Patients Affected by Metastatic TNBC Treated With Upfront Atezolizumab Plus Nab-paclitaxel (TIP)

Sponsor: Fondazione per la Medicina Personalizzata

Conditions Metastatic Triple-negative Breast Cancer
Interventions Tissue Immune Profile
Updated 6 times since 2023 Last updated: May 3, 2023 Started: Sep 16, 2022 Primary completion: Sep 16, 2025 Completion: Sep 16, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Metastatic Triple-negative Breast Cancer and is currently ongoing. Fondazione per la Medicina Personalizzata leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – present · 8 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Oct 2025 — Present [monthly]

    Unknown

    Status: Recruiting → Unknown

  2. Sep 2025 — Oct 2025 [monthly]

    Recruiting

  3. Sep 2024 — Sep 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Jun 2023 — Jul 2024 [monthly]

    Recruiting

▶ Show 1 earlier version

  1. May 2023 — Jun 2023 [monthly]

    Recruiting

    First recorded

Sep 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondazione per la Medicina Personalizzata
  • University of Roma La Sapienza
Data source: Fondazione per la Medicina Personalizzata

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations